脊髓灰质炎,Poliomyelitis
1)Poliomyelitis[英][,p?uli?umai?'laitis][美][,pol?o,ma??'la?t?s]脊髓灰质炎
1.Prospective Analysis on Strategy of OPV Switching to Sabin-IPV at the Endgame of Poliomyelitis Eradication in China;中国在消灭脊髓灰质炎(脊灰)后期使用赛宾株-脊灰灭活疫苗替代口服脊灰减毒活疫苗策略的前瞻性分析
2.Surveillance on Poliomyelitis Antibody Level of Population in Hangzhou;杭州市人群脊髓灰质炎抗体水平监测结果
3.Surveillance and Running Status of Laboratories Network for Poliomyelitis in China in 2006;中国2006年脊髓灰质炎实验室网络的运转与监测
英文短句/例句

1.sugar pills of live poliomyelitis vaccine脊髓灰质炎活菌苗糖丸
2.oral poliomyelitis vaccine口服脊髓灰质炎疫苗
3.infantile paralysis【医】小儿麻痹, 脊髓灰质炎
4.nonparalytic poliomyelitis非麻痹型脊髓灰质炎, 非瘫痪性脊髓灰质炎
5.late effects of acute poliomyelitis急性脊髓灰质炎后遗影响
6.One of the polio vaccines is a killed vaccine.一种脊髓灰质炎疫苗就是死病毒疫苗。
7.Twenty-year Surveillance on Virology of Poliomyelitis in Shaanxi Province陕西省脊髓灰质炎病毒学监测20年
8.By 1995 poliomyelitis had been totally eliminated.1995年,西藏已消灭脊髓灰质炎
9.T1 phage displayed a higher survival than poliovirus.噬菌体的存活高于脊髓灰质炎病毒。
10.Analysis of Poliomyelitis Epidemic Disease Situation in Hubei Province from 1989 to 1992湖北省1989~1992年脊髓灰质炎疫情分析
11.ANALYSIS OF INCIDENCE OF POLIOMYELITIS FROM 1991 TO 1995 IN ANHUI PROVINCE安徽省1991~1995年脊髓灰质炎疫情分析
12.Cost-benefit Analysis on Poliomyelitis Eradication Policies in Sichuan Province四川省消灭脊髓灰质炎成本效益分析
13.Surveillance and Quality Status of Labortory for Poliomyelitis in Hebei Province in 20072007年河北省脊髓灰质炎实验室监测与质量评价
14.a vaccine consisting of inactivated poliovirus that is injected subcutaneously to provide immunity to poliomyelitis.一种为了提高小儿急性脊髓灰质炎的通过皮下注射的由不活跃的脊髓灰质炎病毒组成的疫苗。
15.An enterovirus, separable into three serotypes, that is the causative agent of poliomyelitis.脊髓灰质炎病毒一种肠道病毒,可分为三种血清型,它是导致脊髓灰质炎的媒介
16.Salk vaccine【药】索尔克氏疫苗;脊髓灰质炎菌苗(预防小儿麻痹)
17.Poliomyelitis is a disease known to the civilized world for many centuries.脊髓灰质炎已是文明世界许多世纪所知的疾
18.Analysis of results about polio laboratroy surveiuance in Anhui province from 1991 to 1995安徽省1991~1995年脊髓灰质炎实验室监测结果分析
相关短句/例句

Polio[英]['p??li??][美]['pol?o]脊髓灰质炎
1.Current Situation of Research on Vaccine-Associated Paralytic Poliomyelitis of Oral Polio Vaccine;口服脊髓灰质炎减毒活疫苗相关病例研究现状
2.Objective:To analysis the world polio cases from 1980 to 2005.目的:分析1980-2005年各国脊髓灰质炎发病例数的变化,主要的发病国家,当前全球消灭脊髓灰质炎面临的一些新的挑战。
3.Virological isolation and identification were carried out in accordance with WHO standards,and all polio-positive strains were sent to National Poliomylitis Laboratory for type determination.目的评价湖南省2001~2005年急性弛缓性麻痹(AFP)病例病毒学监测情况,巩固无脊髓灰质炎(脊灰)成果。
3)poliovirus[英][,p?uli?u'vai?r?s][美]['polio,va?r?s]脊髓灰质炎病毒
1.Establishment of cell infection model for inactivation of poliovirus in water;PEG6000沉淀结合差速离心方法浓缩水中脊髓灰质炎病毒
2.Study on the Genes of Poliovirus Type I Isolated fromEnvironmental Water by PCR;PCR法检测外环境水中脊髓灰质炎病毒Ⅰ型基因的研究
3.Study on construction and expression of chimeric plasmid of HIV-1 CN54 strain gagprotease gene and Poliovirus cDNA;HIV-I CN54株gagprotease基因嵌合脊髓灰质炎病毒cDNA质粒的构建和表达研究(英文)
4)poliomyelitis vaccine脊髓灰质炎疫苗
1.s OBJECTIVES To study the connection between effectiveness of the poliomyelitis vaccine and interval after breast-feeding for infants,and to explore the how breast feeding affect oral administration of poliomyelitis vaccine.目的研究婴儿口服脊髓灰质炎疫苗(糖丸)的成功率与哺乳后间隔时间的关系,探讨哺乳后对口服糖丸的影响。
5)poliomyelitis virus脊髓灰质炎病毒
1.Poliomyelitis virus was inoculated into Vero cells cul-tured in 550 L bioreactor,then the CPE was observed and the infectious titer was determined.目的应用生物反应器大规模培养脊髓灰质炎病毒。
2.Methods Poliomyelitis virus Sabin strain typesⅠ,ⅡandⅢwere inoculated onto Vero cells at MOIs of 0.目的探讨Sabin株脊髓灰质炎病毒在Vero细胞上的传代稳定性。
6)Poliomyelitis-like类脊髓灰质炎
延伸阅读

脊髓灰质炎脊髓灰质炎poliomyelitis由脊髓灰质炎病毒引起的急性传染病。因常引起小儿的弛缓性瘫痪,故又称小儿麻痹症。1954年美国科学家Q.索尔克发现造成脊髓灰质炎的病毒,研制出皮下注射疫苗,后A.萨宾研制成功可终生免疫的口服疫苗。该病毒属微小核糖核酸病毒科肠道病毒属。有Ⅰ、、3个血清型,3型之间有一定的交叉免疫反应,但不完全,因此应用疫苗预防时,必须3型都用;又由于3个型别的病毒在肠道中繁殖时可互相干扰,因此3个型别的疫苗应当分3次服用,每次间隔6~8周。病毒主要通过粪-口传播,侵入人体后主要在淋巴结及血中繁殖,仅1%~2%能侵入中枢神经系统,故绝大多数病人表现为顿挫型(类似感冒),病毒侵入神经系统后则可引起无菌性脑膜炎,也可引起瘫痪,少数病人可遗留瘫痪后遗症。口服减毒活疫苗的预防效果很好,如果小儿能普遍服用即可控制该病。疫苗为活疫苗,须冷冻保存。